comparemela.com

Latest Breaking News On - Dean follman - Page 2 : comparemela.com

FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig s disease, a potential setback for patient groups who have lobbied for the medication s approval.

FDA panel sides against experimental ALS drug by Amylyx

The Food and Drug Administration will make the final decision on whether to grant approval for the Lou Gehrig's disease drug by July.

Panelists vote no on drug for ALS

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.